REFERENCES
- Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1982; 19: 410–15.
- Zatz R, Meyer TW, Anderson S, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Nat Acad Sci USA 1985; 82: 5963–7.
- Yaun BH, Robinette JB, Conger JD. Effect of angiotensin II and norepinephrine on isolated rat afferent arterioles. Am J Physiol 1990; 258: F741—F750.
- Erman A, van Dyk DJ, Chen-Gal B, Iskera D, Giler S, Rosenfeld JB, Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615–20.
- Valentovic MA, Elliott CW, Ball JG. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme acti-vity. Res Commun Chem Pathol Pharmacol 1987; 58: 27–38.
- Anderson S, Jung FF, Ingelfinger JR. Renal renin—angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993; 265: F477—F486.
- van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I diabetic patients. Eur J Chin Invest 1994; 24: 463–7.
- Erman A, Chen-Gal B, Zabludowski J, Rosen-feld JB. Cyclosporine A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 1990; 42: 425–7.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin reagent. J Chem Biol 1951; 193: 265–75.
- Bradford AA. A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of dye binding. Ann Biochem 1976; 72: 248–54.
- Christlieb AR, Long R, Underwood RH. Renin—angiotensin—aldosterone system, electro-lyte homeostasis and blood pressure in alloxan diabetes. Am J Med Sci 1979; 277: 295–303.
- Christlieb AR. Renin, angiotensin, and norepine-phrine in alloxan diabetes. Diabetes 1974; 23: 962–70.
- Flordal PR. The plasma dilution factor: Predict-ing how concentrations in plasma and serum are affected by blood volume variations and blood loss. J Lab Clin Med 1995; 126: 353–7.
- Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990; 16: 363–70.
- Correa-Rotter R, Hostetter TH, Rosenberg ME. Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 1992; 41: 796–804.
- Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–30.